NewAmsterdam Pharma Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - NewAmsterdam Pharma
Summary
NAARDEN, the Netherlands and MIAMI, May 01, 2026 (GLOBE NEWSWIRE) -- NewAmsterdam Pharma Company N.V. (NASDAQ:NAMS), a late-stage, clinical biopharmaceutical co...
Original reporting
Open original sourceAFBytes is a read-only aggregator. Use the original source for full context and complete reporting.